Research records indexed for Hexarelin
This page carries 12 of the 327 records that the literature query returned for Hexarelin, selected by citation count and preferring records that name the compound in their title. It is a selection, not a complete index, and the 315 records it does not carry are not represented here. Every row resolves to a real identifier and names the study model, so no finding reads as a human claim by default. The compound page is Hexarelin.
Indexed records
| Record | Year | Study type | Model | n as stated | What it reported |
|---|---|---|---|---|---|
| Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia pmid:29026190 | 2017 | Research Support, Non-U.S. Gov't, research-article | rodent | Not stated | Indexed as research support, non-u.s. gov't, research-article. study model from MeSH "Rats". subject headings: Muscle, Skeletal; Mitochondria; Disease Models, Animal; Body Weight; Cachexia. |
| Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin pmid:25869809 | 2015 | Research Support, Non-U.S. Gov't, Validation Study | other | Not stated | Indexed as research support, non-u.s. gov't, validation study. study model from MeSH "Humans" with no interventional publication type. subject headings: Oligopeptides; Urinalysis; Chromatography, Liquid; Administration, Intranasal; Substance Abuse Detection. |
| Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus pmid:21914437 | 2011 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Rats, Sprague-Dawley; Seizures; Status Epilepticus; Disease Models, Animal; Pilocarpine. |
| Hexarelin suppresses high lipid diet and vitamin D3-induced atherosclerosis in the rat pmid:19931584 | 2010 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Muscle, Smooth, Vascular; Aorta; Rats, Sprague-Dawley; Nitric Oxide; Cholecalciferol. |
| Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro pmid:14615277 | 2004 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Cells, Cultured; Myocytes, Cardiac; Animals, Newborn; Rats, Sprague-Dawley; Tetrazolium Salts. |
| Natural (ghrelin) and synthetic (hexarelin) GH secretagogues stimulate H9c2 cardiomyocyte cell proliferation pmid:12379504 | 2002 | Comparative Study, Research Support, Non-U.S. Gov't | other | Not stated | Indexed as comparative study, research support, non-u.s. gov't. study model from MeSH "Humans" with no interventional publication type. subject headings: Cell Line; Myocytes, Cardiac; Peptide Hormones; Growth Hormone; Oligopeptides. |
| Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone pmid:11238504 | 2001 | Comparative Study, Clinical Trial | human trial | Not stated | Indexed as comparative study, clinical trial. study model from MeSH "Humans" with publication type "clinical trial". subject headings: Aldosterone; Hydrocortisone; Prolactin; Peptide Hormones; Human Growth Hormone. |
| Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death pmid:11322493 | 2001 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Heart; Endothelium; Cells, Cultured; Cell Line; Cell Membrane. |
| The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction pmid:10614623 | 2000 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Myocardium; Heart; Rats, Sprague-Dawley; Myocardial Infarction; Body Weight. |
| Differential orexigenic effects of hexarelin and its analogs in the rat hypothalamus: indication for multiple growth hormone secretagogue receptor subtypes pmid:11146415 | 2000 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Hypothalamus; Paraventricular Hypothalamic Nucleus; Preoptic Area; Ventromedial Hypothalamic Nucleus; Rats, Sprague-Dawley. |
| Growth hormone-independent cardioprotective effects of hexarelin in the rat pmid:10465272 | 1999 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Myocardium; Heart; Rats, Sprague-Dawley; Myocardial Reperfusion Injury; Myocardial Ischemia. |
| The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin pmid:10404825 | 1999 | Clinical Trial, Randomized Controlled Trial | human trial | Not stated | Indexed as clinical trial, randomized controlled trial. study model from MeSH "Humans" with publication type "clinical trial". subject headings: Adrenal Glands; Pituitary Gland; Hypothalamus; Hydrocortisone; Prolactin. |
Where this page sits
Compound page: Hexarelin. Class: Growth hormone secretagogues.
Retrieved 2026-10-10.
Sources
- PubChem Compound Summary for CID 6918297, Examorelin. PubChem, National Library of Medicine (2026). pubchem:6918297
- Drugs@FDA application register query for this compound, no application records returned. U.S. Food and Drug Administration, openFDA drugsfda endpoint (2026). fda:hexarelin
- Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man. J Clin Endocrinol Metab (1994). pmid:8126144
- GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats. Life Sci (1994). pmid:7910650
- Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab (2001). pmid:11238504
- Growth hormone-independent cardioprotective effects of hexarelin in the rat. Endocrinology (1999). pmid:10465272
- Natural (ghrelin) and synthetic (hexarelin) GH secretagogues stimulate H9c2 cardiomyocyte cell proliferation. J Endocrinol (2002). pmid:12379504
On each stated value was matched to the record cited for it. That is record matching, not an appraisal of the research. Compiled and checked by: Peptide Monographs editorial desk. No qualified clinical reviewer.